Skip to main content

Crowley John F's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed Jan 19, 2022

Accession no.
0001209191-22-003820
Filed
Jan 19, 2022
Trade date
Jan 14-18, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $87.6K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crowley John FCIK 0001400973Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 14, 2022Common StockAGrant or awardAcquired+239,099–F2–894,230Direct
Jan 14, 2022Common StockAGrant or awardAcquired+149,660–F3–1,043,890Direct
Jan 14, 2022Common StockFTax withholdingDisposed−58,891$10.53−$620,122.23984,999Direct
Jan 18, 2022Common StockSSaleDisposed−8,564$10.23−$87,609.72976,435Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 14, 2022Common StockAGrant or awardAcquired+438,222$0.00$0438,222Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.

Referenced by the price of 1 transaction in Table I.

F3

Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.

Referenced by the price of 1 transaction in Table I.

Remarks

In addition to the reported transactions, Mr. Crowley also has approximately 403,000 options outstanding and exercisable at various strike prices.

Read the full filing on SEC EDGAR (opens in a new tab)